On the Record · BioNTech
BioNTech competitors, on the record
The companies BioNTech names as competitors in its annual reports, 2023 to 2025, and the companies that name BioNTech, each with the sentence and the filing.
Who BioNTech names
| Company | Named in |
|---|---|
| Moderna, Inc. | 2025 |
| Novavax, Inc. | 2025 |
In its own words
Moderna, Inc., Novavax, Inc.
Word for word“A number of competitors currently have programs to develop COVID-19 vaccine candidates, including vaccines developed by Moderna, Inc. and Novavax, Inc .” 20-F for 2025
Who names BioNTech
Companies whose own annual reports name BioNTech as a competitor.
Word for word“We largely compete against Pfizer and BioNTech for sales of our COVID vaccines, whose vaccine is also based on mRNA technology.” 10-K for 2025
Read from BioNTech’s annual reports (20-F for 2025, 20-F for 2024, 20-F for 2023) and the financial data it files with the SEC, as of 2026-03-10. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.